Your browser doesn't support javascript.
loading
From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.
Herrera, Crystal M; Schmitt, Jessicia S; Chowdhry, Erum I; Riddle, Mark S.
Afiliación
  • Herrera CM; Reno School of Medicine, University of Nevada, Reno, NV 89557, USA.
  • Schmitt JS; Reno School of Medicine, University of Nevada, Reno, NV 89557, USA.
  • Chowdhry EI; Reno School of Medicine, University of Nevada, Reno, NV 89557, USA.
  • Riddle MS; Reno School of Medicine, University of Nevada, Reno, NV 89557, USA.
Vaccines (Basel) ; 10(5)2022 Apr 20.
Article en En | MEDLINE | ID: mdl-35632401
We are at an exciting moment in time with the advancement of many vaccines, including a shigella vaccine for the world. It is instructive to look at the long road that some vaccines have traveled to recognize the remarkable accomplishments of those who were pioneers, appreciate the evolution of scientific and applied technology, and inform the future history of a vaccine that would have great potential for global health. To achieve this valuable retrospective, a narrative historical literature review was undertaken utilizing PubMed and Embase databases with relevant search terms. Retrieved articles were reviewed and information was organized into historical themes, landmark discoveries, and important vaccine development parallels. The literature reviewed was synthesized into major eras of shigella vaccine development from pathogen discovery and first attempts to empirical approaches of killed whole-cell and live-attenuated approaches, and a modern era that applied recombinant DNA engineering and structural vaccinology. The history of shigella vaccine development has largely followed the evolutionary path of vaccine development over the last 120 years, but with important lessons learned that should be considered as we embark on the future chapters of bringing to the world a safe and effective vaccine for global health.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_cobertura_universal / 3_diarrhea Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_cobertura_universal / 3_diarrhea Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...